{
  "ptid_time": "141_S_1052_2010-11-23",
  "img_path": "/data/qiuhui/data/adni/images/141_S_1052/2010-11-23/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 34,464 mm³, 22.8% above the reference mean. With a Z-score of 0.52 (69.9th percentile), this represents normal volume ; hippocampal volume measures 6,212 mm³, 12.7% below the reference mean. With a Z-score of -1.16 (12.2th percentile), this represents mild atrophy; whole brain volume measures 888,107 mm³, 8.9% below the reference mean. With a Z-score of -1.12 (13.2th percentile), this represents mild atrophy; entorhinal cortex volume measures 3,340 mm³, 9.1% below the reference mean. With a Z-score of -0.56 (28.9th percentile), this represents normal volume ; fusiform gyrus volume measures 15,056 mm³, 11.5% below the reference mean. With a Z-score of -1.05 (14.8th percentile), this represents mild atrophy; middle temporal gyrus volume measures 22,294 mm³, 16.3% above the reference mean. With a Z-score of 1.41 (92.1th percentile), this represents mild enlargement. ",
  "text_data": "Age is 73.0 years. Gender is Female. Education: 8 years. MoCA: 18.0. Logical Memory: 5.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 0.85 SUVR (moderate reduced). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows mild atrophy in the hippocampus, whole brain, and fusiform gyrus, which are regions commonly affected in Alzheimer's disease. The MoCA score of 18 indicates cognitive impairment, and the presence of one APOE4 allele increases Alzheimer's risk. The moderate reduction in AV45 (amyloid PET) suggests amyloid pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**, likely due to Alzheimer's pathology.  \n\n**Confidence:** **Medium** (due to the absence of severe atrophy or dementia-level cognitive scores, but strong biomarker support for early Alzheimer's changes).",
  "timestamp": "2025-07-26T16:54:03.395110"
}